Liraglutide studies: 1,219 papers with results
Page 23 of 25
- Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies.
Zhang Z · Diabetes care · 2019
Not a test of Liraglutide alone · 3 results
- Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-analysis.
Piccoli GF · The Journal of clinical endocrinology and metabolism · 2021
Not a test of Liraglutide alone · 3 results
- Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.
Xie Z · Metabolism: clinical and experimental · 2024
Not a test of Liraglutide alone · 32 results
- Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials.
Qin J · BMC endocrine disorders · 2022
Not a test of Liraglutide alone · 6 results
- Areas of Interest and Attitudes Toward Antiobesity Drugs: Thematic and Quantitative Analysis Using Twitter.
Alvarez-Mon MA · Journal of medical Internet research · 2021
Not a test of Liraglutide alone · 7 results
- Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach.
Overgaard RV · Diabetes, obesity & metabolism · 2019
Not a test of Liraglutide alone · 6 results
- Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.
Glaros SB · Gut microbes · 2025
Not a test of Liraglutide alone · 3 results
- Effects of treatment with Glucagon-like peptide-1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta-analysis.
Wang W · Diabetes/metabolism research and reviews · 2023
Not a test of Liraglutide alone · 3 results
- Glucagon-like peptide receptor agonists and risk for depression.
Tagliapietra GA · Primary care diabetes · 2024
Not a test of Liraglutide alone · 6 results
- Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 mg.
Tronieri JS · Behaviour research and therapy · 2020
Not a test of Liraglutide alone · 3 results
- The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2.
Dilla T · Journal of medical economics · 2017
Not a test of Liraglutide alone · 6 results
- Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: a network meta-analysis.
Yuan X · Frontiers in endocrinology · 2023
Not a test of Liraglutide alone · 11 results
- A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c ≥9-15%: DUAL HIGH Trial.
Galindo RJ · Diabetes care · 2023
Not a test of Liraglutide alone · 3 results
- One-year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes.
Taybani ZJ · Endocrinology, diabetes & metabolism · 2023
Not a test of Liraglutide alone · 3 results
- Fast-track rescue weight reduction therapy to achieve rapid technical operability for emergency bariatric surgery in patients with life-threatening inoperable severe obesity - A proof of concept study.
Stier C · Clinical nutrition ESPEN · 2022
Not a test of Liraglutide alone · 3 results
- Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA.
Sinha B · Obesity (Silver Spring, Md.) · 2025
Not a test of Liraglutide alone · 12 results
- Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): A systematic review and meta-analysis of observational cohort studies.
Herrera Comoglio R · International journal of clinical practice · 2020
Not a test of Liraglutide alone · 3 results
- Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.
Marcum ZA · The Annals of pharmacotherapy · 2015
Not a test of Liraglutide alone · 3 results
- Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.
Bardóczi A · Sleep medicine reviews · 2025
Not a test of Liraglutide alone · 6 results
- Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide.
Fortin SM · Physiology & behavior · 2020
Not a test of Liraglutide alone · 4 results
- Impact of GLP-1 receptor agonists on upper gastrointestinal endoscopy: an updated systematic review and meta-analysis.
Abdulraheem A · Surgical endoscopy · 2025
Not a test of Liraglutide alone · 6 results
- Ideglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared with Insulin Glargine U100 Plus Insulin Aspart in the U.S.
Dempsey M · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2018
Not a test of Liraglutide alone · 3 results
- The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Hollander PA · Diabetes care · 2024
Not a test of Liraglutide alone · 3 results
- Patients With Severe Obesity Are Made Eligible for Complex Abdominal Wall Repair After Preoptimization With GLP-1 Agonists: Results of a Bicentric Pilot Study.
Romain B · World journal of surgery · 2025
Not a test of Liraglutide alone · 10 results
- Evaluation of Drug Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors Based on Target Molecular Binding Occupancy.
Takayanagi R · Biological & pharmaceutical bulletin · 2018
Not a test of Liraglutide alone · 3 results
- Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US.
Dempsey M · Journal of medical economics · 2018
Not a test of Liraglutide alone · 3 results
- Cost-Effectiveness of Dulaglutide Versus Liraglutide for Management of Type 2 Diabetes Mellitus in Iran.
Ekhlasi M · Value in health regional issues · 2022
Not a test of Liraglutide alone · 6 results
- GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.
Giugliano D · Diabetes, obesity & metabolism · 2026
Not a test of Liraglutide alone · 9 results
- Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide.
Oe Y · Frontiers in endocrinology · 2025
Not a test of Liraglutide alone · 7 results
- Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine.
Medak KD · iScience · 2024
Not a test of Liraglutide alone · 8 results
- Are glucagon-like peptide 1 analogues effective and safe in severe COVID-19 patients with type 2 diabetes?-a case report.
Chen S · Annals of palliative medicine · 2021
Not a test of Liraglutide alone · 3 results
- GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study.
King AC · Journal of addiction medicine · 2026
Not a test of Liraglutide alone · 9 results
- Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus.
Park MJ · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026
Not a test of Liraglutide alone · 12 results
- Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population.
Liu H · Journal of diabetes investigation · 2022
Not a test of Liraglutide alone · 3 results
- GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review.
Myśliwczyk D · Nutrients · 2026
Not a test of Liraglutide alone · 10 results
- Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis.
Yang Q · BMC ophthalmology · 2026
Not a test of Liraglutide alone · 8 results
- Weight loss and β-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial.
Utzschneider KM · Obesity (Silver Spring, Md.) · 2022
Not a test of Liraglutide alone · 3 results
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review.
Mantovani A · The lancet. Gastroenterology & hepatology · 2022
Not a test of Liraglutide alone · 4 results
- Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
Mearns ES · PloS one · 2015
Not a test of Liraglutide alone · 2 results
- A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
Nørregaard PK · Diabetes, obesity & metabolism · 2018
Not a test of Liraglutide alone · 2 results
- Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis.
Cao B · Diabetes, obesity & metabolism · 2018
Not a test of Liraglutide alone · 2 results
- Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis.
Monami M · Experimental diabetes research · 2012
Not a test of Liraglutide alone · 4 results
- Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.
Barrett TS · JAMA surgery · 2025
Not a test of Liraglutide alone · 9 results
- Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study.
Samson SL · Pituitary · 2021
Not a test of Liraglutide alone · 2 results
- Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States.
Langer J · Journal of managed care pharmacy : JMCP · 2013
Not a test of Liraglutide alone · 2 results
- Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.
Ukhanova M · The American journal of managed care · 2025
Not a test of Liraglutide alone · 4 results
- Pharmacological Treatment for Obesity in Adults: An Umbrella Review.
Khalil H · The Annals of pharmacotherapy · 2020
Not a test of Liraglutide alone · 2 results
- Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis.
Hansen BB · Journal of medical economics · 2020
Not a test of Liraglutide alone · 8 results
- Effects of GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis.
Fang L · Primary care diabetes · 2024
Not a test of Liraglutide alone · 2 results
- Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.
Hunt B · Journal of medical economics · 2017
Not a test of Liraglutide alone · 2 results